2021 annual financial data
Aurinia Pharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -345.78%.
Operating income was -180,735,000 USD and net income was -180,966,000 USD.
Operating cash flow was -157,692,000 USD.
Get free Aurinia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 45,605,000 USD
- Operating income
- -180,735,000 USD
- Net income
- -180,966,000 USD
- Operating cash flow
- -157,692,000 USD